These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1510416)

  • 1. Excretion of cefprozil into human breast milk.
    Shyu WC; Shah VR; Campbell DA; Venitz J; Jaganathan V; Pittman KA; Wilber RB; Barbhaiya RH
    Antimicrob Agents Chemother; 1992 May; 36(5):938-41. PubMed ID: 1510416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antacid on the bioavailability of cefprozil.
    Shyu WC; Wilber RB; Pittman KA; Barbhaiya RH
    Antimicrob Agents Chemother; 1992 May; 36(5):962-5. PubMed ID: 1510420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humans.
    Shyu WC; Shah VR; Campbell DA; Wilber RB; Pittman KA; Barbhaiya RH
    J Clin Pharmacol; 1992 Sep; 32(9):798-803. PubMed ID: 1430299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
    Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
    J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.
    Shukla UA; Pittman KA; Barbhaiya RH
    J Clin Pharmacol; 1992 Aug; 32(8):725-31. PubMed ID: 1487562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefprozil in healthy subjects and patients with hepatic impairment.
    Shyu WC; Wilber RB; Pittman KA; Garg DC; Barbhaiya RH
    J Clin Pharmacol; 1991 Apr; 31(4):372-6. PubMed ID: 2037711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefprozil in infants and children.
    Sáez-Llorens X; Shyu WC; Shelton S; Kumiesz H; Nelson J
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2152-5. PubMed ID: 2073105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of cefprozil into tonsillar and adenoidal tissues.
    Shyu WC; Reilly J; Campbell DA; Wilber RB; Barbhaiya RH
    Antimicrob Agents Chemother; 1993 May; 37(5):1180-3. PubMed ID: 8517711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of multiple-dose cefprozil and comparison with cefaclor.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Martin RR; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1198-203. PubMed ID: 2393281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute bioavailability of cefprozil after oral administration in beagles.
    Barbhaiya RH; Wang L; Shyu WC; Pittman KA
    Antimicrob Agents Chemother; 1992 Mar; 36(3):687-9. PubMed ID: 1622187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.
    Lode H; Müller C; Borner K; Nord CE; Koeppe P
    Antimicrob Agents Chemother; 1992 Jan; 36(1):144-9. PubMed ID: 1590680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1204-9. PubMed ID: 2393282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous high-performance liquid chromatographic analysis of cefprozil diastereomers in a pharmacokinetic study.
    Shyu WC; Shukla UA; Shah VR; Papp EA; Barbhaiya RH
    Pharm Res; 1991 Aug; 8(8):992-6. PubMed ID: 1924169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC method for simultaneous determination of cefprozil diastereomers in human plasma.
    Park TH; Kim JK; Jee JP; Park JS; Kim CK
    J Pharm Biomed Anal; 2004 Sep; 36(1):243-8. PubMed ID: 15351073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of food on the pharmacokinetics of cefprozil and cefaclor.
    Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Pittman KA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1210-3. PubMed ID: 2393283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics of
    Jang JH; Jeong SH; Cho HY; Lee YB
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31614996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
    Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
    PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.
    Nicolau DP; Sutherland CA; Arguedas A; Dagan R; Pichichero ME
    Paediatr Drugs; 2007; 9(2):119-23. PubMed ID: 17407367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of cefprozil into middle ear fluid of patients with otitis media.
    Shyu WC; Haddad J; Reilly J; Khan WN; Campbell DA; Tsai Y; Barbhaiya RH
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2210-2. PubMed ID: 7811050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of time of administration and posture on the pharmacokinetics of cefprozil.
    Shyu WC; Gleason CR; Barbhaiya RH
    Clin Pharmacokinet; 1993 Sep; 25(3):237-42. PubMed ID: 8222462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.